These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31483651)

  • 1. Heteroaryl Phosphonates as Noncovalent Inhibitors of Both Serine- and Metallocarbapenemases.
    Pemberton OA; Jaishankar P; Akhtar A; Adams JL; Shaw LN; Renslo AR; Chen Y
    J Med Chem; 2019 Sep; 62(18):8480-8496. PubMed ID: 31483651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Faropenem reacts with serine and metallo-β-lactamases to give multiple products.
    Lucic A; Hinchliffe P; Malla TR; Tooke CL; Brem J; Calvopiña K; Lohans CT; Rabe P; McDonough MA; Armistead T; Orville AM; Spencer J; Schofield CJ
    Eur J Med Chem; 2021 Apr; 215():113257. PubMed ID: 33618159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azetidinimines as a novel series of non-covalent broad-spectrum inhibitors of β-lactamases with submicromolar activities against carbapenemases KPC-2 (class A), NDM-1 (class B) and OXA-48 (class D).
    Romero E; Oueslati S; Benchekroun M; D'Hollander ACA; Ventre S; Vijayakumar K; Minard C; Exilie C; Tlili L; Retailleau P; Zavala A; Elisée E; Selwa E; Nguyen LA; Pruvost A; Naas T; Iorga BI; Dodd RH; Cariou K
    Eur J Med Chem; 2021 Jul; 219():113418. PubMed ID: 33862516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approved Drugs Containing Thiols as Inhibitors of Metallo-β-lactamases: Strategy To Combat Multidrug-Resistant Bacteria.
    Klingler FM; Wichelhaus TA; Frank D; Cuesta-Bernal J; El-Delik J; Müller HF; Sjuts H; Göttig S; Koenigs A; Pos KM; Pogoryelov D; Proschak E
    J Med Chem; 2015 Apr; 58(8):3626-30. PubMed ID: 25815530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfamoyl Heteroarylcarboxylic Acids as Promising Metallo-β-Lactamase Inhibitors for Controlling Bacterial Carbapenem Resistance.
    Wachino JI; Jin W; Kimura K; Kurosaki H; Sato A; Arakawa Y
    mBio; 2020 Mar; 11(2):. PubMed ID: 32184250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-Alkyl-1,2,4-triazole-3-thione analogues as metallo-β-lactamase inhibitors.
    Gavara L; Legru A; Verdirosa F; Sevaille L; Nauton L; Corsica G; Mercuri PS; Sannio F; Feller G; Coulon R; De Luca F; Cerboni G; Tanfoni S; Chelini G; Galleni M; Docquier JD; Hernandez JF
    Bioorg Chem; 2021 Aug; 113():105024. PubMed ID: 34116340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virtual screening identifies broad-spectrum β-lactamase inhibitors with activity on clinically relevant serine- and metallo-carbapenemases.
    Spyrakis F; Santucci M; Maso L; Cross S; Gianquinto E; Sannio F; Verdirosa F; De Luca F; Docquier JD; Cendron L; Tondi D; Venturelli A; Cruciani G; Costi MP
    Sci Rep; 2020 Jul; 10(1):12763. PubMed ID: 32728062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and Preclinical Evaluation of TPA-Based Zinc Chelators as Metallo-β-lactamase Inhibitors.
    Schnaars C; Kildahl-Andersen G; Prandina A; Popal R; Radix S; Le Borgne M; Gjøen T; Andresen AMS; Heikal A; Økstad OA; Fröhlich C; Samuelsen Ø; Lauksund S; Jordheim LP; Rongved P; Åstrand OAH
    ACS Infect Dis; 2018 Sep; 4(9):1407-1422. PubMed ID: 30022668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural studies of triazole inhibitors with promising inhibitor effects against antibiotic resistance metallo-β-lactamases.
    Muhammad Z; Skagseth S; Boomgaren M; Akhter S; Fröhlich C; Ismael A; Christopeit T; Bayer A; Leiros HS
    Bioorg Med Chem; 2020 Aug; 28(15):115598. PubMed ID: 32631568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The structure of the metallo-β-lactamase VIM-2 in complex with a triazolylthioacetamide inhibitor.
    Christopeit T; Yang KW; Yang SK; Leiros HK
    Acta Crystallogr F Struct Biol Commun; 2016 Nov; 72(Pt 11):813-819. PubMed ID: 27834790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of imipenem resistance in metallo-β-lactamases expressing pathogenic bacterial spp. and identification of potential inhibitors: An in silico approach.
    Malathi K; Ramaiah S
    J Cell Biochem; 2019 Jan; 120(1):584-591. PubMed ID: 30125985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Role of Residue 228 in Substrate and Inhibitor Recognition by VIM Metallo-β-lactamases.
    Mojica MF; Mahler SG; Bethel CR; Taracila MA; Kosmopoulou M; Papp-Wallace KM; Llarrull LI; Wilson BM; Marshall SH; Wallace CJ; Villegas MV; Harris ME; Vila AJ; Spencer J; Bonomo RA
    Biochemistry; 2015 May; 54(20):3183-96. PubMed ID: 25915520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of 3-aryl substituted benzoxaboroles as broad-spectrum inhibitors of serine- and metallo-β-lactamases.
    Yan YH; Li ZF; Ning XL; Deng J; Yu JL; Luo Y; Wang Z; Li G; Li GB; Xiao YC
    Bioorg Med Chem Lett; 2021 Jun; 41():127956. PubMed ID: 33744439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a Cyclic Boronic Acid β-Lactamase Inhibitor (RPX7009) with Utility vs Class A Serine Carbapenemases.
    Hecker SJ; Reddy KR; Totrov M; Hirst GC; Lomovskaya O; Griffith DC; King P; Tsivkovski R; Sun D; Sabet M; Tarazi Z; Clifton MC; Atkins K; Raymond A; Potts KT; Abendroth J; Boyer SH; Loutit JS; Morgan EE; Durso S; Dudley MN
    J Med Chem; 2015 May; 58(9):3682-92. PubMed ID: 25782055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bicyclic Boronate VNRX-5133 Inhibits Metallo- and Serine-β-Lactamases.
    Krajnc A; Brem J; Hinchliffe P; Calvopiña K; Panduwawala TD; Lang PA; Kamps JJAG; Tyrrell JM; Widlake E; Saward BG; Walsh TR; Spencer J; Schofield CJ
    J Med Chem; 2019 Sep; 62(18):8544-8556. PubMed ID: 31454231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Investigation of carbapenemases in carbapenem-resistant Escherichia coli and Klebsiella pneumoniae strains isolated in 2014 in Turkey].
    Çakar A; Akyön Y; Gür D; Karatuna O; Öğünç D; Özhak Baysan B; Çöplü N; Çağatay M; Kılıç A; Baysallar M; Bakıcı Z; Çelik C; Gülay Z; Aydemir Ş; Tünger A; Kılıç H; Erçal BD; Aşçı Toraman Z; Zer Y; Büyüktaş A; Ay S; Aktaş Z; Kayacan Ç; Bayramoğlu G; Aydın F; Dündar D; Hasdemir U; Ayaş R; Yanık K; Günaydın M; Güdücüoğlu H; Parlak M
    Mikrobiyol Bul; 2016 Jan; 50(1):21-33. PubMed ID: 27058326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-Based Development of (1-(3'-Mercaptopropanamido)methyl)boronic Acid Derived Broad-Spectrum, Dual-Action Inhibitors of Metallo- and Serine-β-lactamases.
    Wang YL; Liu S; Yu ZJ; Lei Y; Huang MY; Yan YH; Ma Q; Zheng Y; Deng H; Sun Y; Wu C; Yu Y; Chen Q; Wang Z; Wu Y; Li GB
    J Med Chem; 2019 Aug; 62(15):7160-7184. PubMed ID: 31269398
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Barnes MD; Winkler ML; Taracila MA; Page MG; Desarbre E; Kreiswirth BN; Shields RK; Nguyen MH; Clancy C; Spellberg B; Papp-Wallace KM; Bonomo RA
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active-Site Druggability of Carbapenemases and Broad-Spectrum Inhibitor Discovery.
    Torelli NJ; Akhtar A; DeFrees K; Jaishankar P; Pemberton OA; Zhang X; Johnson C; Renslo AR; Chen Y
    ACS Infect Dis; 2019 Jun; 5(6):1013-1021. PubMed ID: 30942078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The complexed structure and antimicrobial activity of a non-beta-lactam inhibitor of AmpC beta-lactamase.
    Powers RA; Blázquez J; Weston GS; Morosini MI; Baquero F; Shoichet BK
    Protein Sci; 1999 Nov; 8(11):2330-7. PubMed ID: 10595535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.